Ajanta Pharma Ltd
Healthcare | Mid Cap
Ajanta Pharma shows a very strong financial profile, marked by exceptional profitability, impressive growth, and an almost debt-free status. The company is very effective at turning sales into profit and is expanding its business and earnings at a rapid rate. This low-debt approach makes it a very stable and low-risk company from a long-term perspective. However, a key area of concern is its operational efficiency. The company takes a long time to sell its products and collect payments from customers, and it does not generate as much revenue as it could from its assets. While it pays dividends, the coverage for these has been thin recently. The future outlook appears positive due to strong growth and profitability, but its success will also depend on how well it manages its day-to-day operations.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio10.00
- Financial Ratio8.40
- Profitability Ratio10.00
- Efficiency Ratio2.67
- Coverage Ratio7.60
- Solvency Ratio10.00
- Liquidity Ratio7.44
- Peer Assessment
- Management AssessmentStrong
- Risk AssessmentStrong
- 1 HourNeutral
- 2 HoursNeutral
- 4 HoursNeutral
- 1 DayBullish
- 1 WeekBullish
- 1 MonthBullish
Ajanta Pharma shows a very strong financial profile, marked by exceptional profitability, impressive growth, and an almost debt-free status. The company is very effective at turning sales into profit and is expanding its business and earnings at a rapid rate. This low-debt approach makes it a very stable and low-risk company from a long-term perspective. However, a key area of concern is its operational efficiency. The company takes a long time to sell its products and collect payments from customers, and it does not generate as much revenue as it could from its assets. While it pays dividends, the coverage for these has been thin recently. The future outlook appears positive due to strong growth and profitability, but its success will also depend on how well it manages its day-to-day operations.
Overall Valuation Score
P/E RATIO (TTM)
40.45
Industry Median
28.62
Mid Cap Median
36.34
P/E RATIO
36.27
P/B RATIO
8.47
Industry Median
3.17
Mid Cap Median
7.64
P/S RATIO
6.95
Industry Median
3.42
Mid Cap Median
6.30
Others
PEG RATIO
0.00
EV/EBITDA RATIO
24.16
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹3065.2 as on Jun 19, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
The company is experiencing a period of outstanding growth across the board. Sales, operating profits, and net income are all expanding at an excellent rate. This strong upward trend indicates high demand for its products and effective management in scaling the business profitably. The expansion of its asset base further supports this growth trajectory, positioning the company well for future performance and market share gains.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 15.61 | 12.03 | 12.45 | 10.43 | 17.32 |
| Operating Profit Growth Rate | -6.79 | -13.4 | 45.05 | 8.28 | 9.93 |
| Earnings Per Share (EPS) Growth | 10.42 | -17.51 | 38.81 | 15.67 | 14.71 |
| Asset Growth Rate | 7.27 | 14.55 | -1.13 | 8.26 | 25.51 |
| Net Income Growth Rate | 9.02 | -17.53 | 38.78 | 12.75 | 14.78 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The company demonstrates a strong financial profile from a shareholder's perspective, with excellent earnings and book value per share. It has also been generous with dividend payments. However, a significant amount of money is being spent on capital expenditures. While these investments are crucial for future growth, they represent a large cash outflow in the present, which is a key factor to note in its financial strategy.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 84 | 47.52 | 64.64 | 73.28 | 84.48 |
| Cash Earnings Per Share (Cash EPS) | 98.59 | 57.52 | 76.08 | 85.12 | 98.32 |
| Book Value Per Share | 384 | 271.04 | 285.36 | 303.2 | 362.16 |
| Dividend Per Share (DPS) | 6.12 | 6.88 | 50.32 | 28 | 0 |
| Capital Expenditures (CapEx) | 131 | 173 | 139 | 317 | 360 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The company's profitability is outstanding. It is highly effective at converting its revenue into profit at every level, from the gross profit on products sold to the final net income. Furthermore, it generates excellent returns on the money invested by both shareholders and lenders. This all-around strength in profitability is a key indicator of superior operational efficiency, strong market positioning, and effective management.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 24.18 | 18.09 | 24.64 | 24.2 | 22.41 |
| Return on Capital Employed (ROCE) | 29 | 23 | 32 | 32 | 32 |
| Return on Equity (ROE) | 21.84 | 17.36 | 22.88 | 24.27 | 23.33 |
| Return on Assets (ROA) | 23.33 | 17.63 | 25.87 | 25.88 | 22.66 |
| Operating Margin | 27.93 | 21.59 | 27.85 | 27.3 | 25.58 |
| Net Margin | 21.34 | 15.71 | 19.39 | 19.79 | 19.37 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The company's performance in managing its assets and operations to generate revenue shows significant room for improvement. It appears to be slow in selling its inventory and collecting payments from its customers. Furthermore, the revenue generated from its fixed assets and overall capital is low. This suggests that while the company is profitable, its operational processes may not be as streamlined or effective as they could be, which can tie up cash and hinder overall performance.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 2.21 | 2.5 | 2.85 | 2.64 | 2.92 |
| Inventory Turnover Ratio | 3.25 | 3.81 | 3.86 | 4.07 | 4.59 |
| Receivables Turnover Ratio | 3.8 | 3.6 | 3.65 | 3.83 | 3.59 |
| Days Sales in Inventory Ratio | 112.31 | 95.8 | 94.56 | 89.68 | 79.52 |
| Receivable Days | 96.05 | 101.39 | 100 | 95.3 | 101.67 |
| Capital Turnover Ratio | 1.02 | 1.09 | 1.17 | 1.21 | 1.19 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The company's position here is mixed. On one hand, its ability to cover interest payments on its debt is exceptionally strong, which is a direct benefit of its low-debt policy and removes any concern in this area. On the other hand, the earnings available to cover dividend payments to shareholders appear thin. This suggests that recent dividend payouts might be high relative to the profits being earned.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 91.9 | 125.17 | 160.14 | 57.62 | 87.12 |
| Equity Dividend Coverage Ratio | 9.09 | 6.67 | 1.27 | 2.63 |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The company's long-term financial stability is exceptionally strong. It operates with virtually no debt, financing its operations almost entirely through its own funds and profits. This extremely low reliance on borrowing means there is minimal risk of the company being unable to meet its long-term obligations. This conservative financial structure provides a very solid foundation for sustainable growth and resilience against economic downturns.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Debt to Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Equity Ratio | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 |
| Debt To Asset Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The company's ability to cover its short-term bills is generally good. It holds enough easily accessible assets, even excluding inventory, to meet its immediate financial obligations, which is a positive sign of stability. However, its cash reserves are relatively low compared to its short-term liabilities. This suggests that while the company is not in immediate danger, it relies more on converting other assets like receivables into cash rather than having a large cash buffer on hand to pay its bills.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 3.08 | 2.02 | 2.64 | 2.34 | 2.18 |
| Quick Ratio | 1.96 | 1.32 | 1.74 | 1.49 | 1.58 |
| Cash Ratio | 0.3 | 0.29 | 0.14 | 0.16 | 0.07 |
| Operating Cash Flow Ratio | 0.79 | 0.68 | 0.85 | 1.08 | 0.33 |
Current Ratios
Quick Ratios
Cash Ratios
Operating Cash Flow Ratios
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Glaxosmithkline Pharmaceuticals Ltd | 8.38 | 38.14 | Neutral | 1309.00 | 59.73 | 1036.00 |
| 2 | J B Chemicals & Pharmaceuticals Ltd | 8.14 | 49.64 | Overvalued | 1107.00 | 41.98 | 709.00 |
| 3 | Gland Pharma Ltd | 7.91 | 35.27 | Overvalued | 1630.00 | 78.88 | 1027.00 |
| 4 | Neuland Laboratories Ltd | 7.84 | 61.14 | Highly Overvalued | 574.00 | 283.01 | 364.00 |
| 5 | Granules India Ltd | 7.73 | 32.77 | Highly Overvalued | 1185.00 | 16.17 | 595.00 |
| 6 | Ajanta Pharma Ltd | 7.72 | 36.27 | Neutral | 1395.00 | 75.78 | 1056.00 |
| 7 | Alembic Pharmaceuticals Ltd | 7.54 | 22.23 | Undervalued | 1118.00 | 32.58 | 671.00 |
| 8 | Syngene International Ltd | 7.44 | 56.08 | Overvalued | 918.00 | 7.55 | 317.00 |
| 9 | Emcure Pharmaceuticals Ltd | 7.40 | 36.42 | Neutral | 1865.00 | 38.66 | 941.00 |
| 10 | ERIS Lifesciences Ltd | 7.15 | 32.39 | Neutral | 1120.00 | 17.61 | 648.00 |
| 11 | Ipca Laboratories Ltd | 6.33 | 35.26 | Neutral | 1979.00 | 44.64 | 1184.00 |
| 12 | Piramal Pharma Ltd | 5.83 | -64.86 | Neutral | 922.00 | 5.27 | -326.00 |
| 13 | Jubilant Pharmova Ltd | 5.71 | 38.62 | Neutral | 1260.00 | 1.25 | 398.00 |
| 14 | Natco Pharma Ltd | 5.69 | 11.22 | Neutral | 1436.00 | 71.55 | 1418.00 |
| 15 | Wockhardt Ltd | 5.07 | 153.40 | Neutral | 652.00 | 19.51 | 199.00 |
| 16 | Pfizer Ltd | 3.45 | 45.16 | Neutral | -82.00 | 157.92 | 300.00 |
Management effectiveness is rated as strong, evidenced by outstanding capital efficiency, robust growth, and prudent financial stewardship. The company demonstrates excellent profitability with a ROCE of 32% and a stable ROE around 25%. Financial performance is marked by accelerating sales and strong profit growth, particularly over the last three years. The balance sheet is virtually debt-free, reflecting a conservative approach to leverage. High and stable promoter ownership, coupled with increasing DII interest, indicates strong confidence in the company's long-term strategy and execution. While the working capital cycle is long, the overall financial health and sustained performance metrics point to highly effective management.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | ROCE | 32% | Excellent capital efficiency |
| Debt/Equity Ratio | 0.01 | Negligible financial risk | |
| 3-Year Profit Growth CAGR | 21% | Strong earnings momentum | |
| Promoter Holding | 66.22% | High promoter conviction | |
| CONS | Cash Conversion Cycle | 233 days | Inefficient working capital |
| Inventory Days | 283 days | High capital tied in inventory |
Financial Performance & Growth
The company exhibits excellent financial performance, characterized by strong and accelerating growth in both revenue and profits. Sales growth has been robust over the long term and has shown recent acceleration, with a TTM growth of 17%. Profit growth is particularly strong over a 3-year horizon at 21% CAGR, and the most recent year (FY24) saw a significant 36% jump in net profit, recovering sharply from a dip in the previous year. This indicates management's ability to drive profitability. Operating profit margins have also recovered to a healthy 28% in FY24 from 22% in FY23, demonstrating effective cost control and operational efficiency. Furthermore, profits are primarily generated from core business operations, with other income contributing less than 8% to pre-tax profits, underscoring the sustainability of the company's earnings power.
Capital Efficiency & Returns
Management demonstrates outstanding capital efficiency, consistently generating high returns. The Return on Capital Employed (ROCE) stands at an excellent 32% for FY2024, a significant improvement from 23% in the prior year and well above the industry median. This indicates highly productive use of capital in generating profits. Similarly, the Return on Equity (ROE) is strong and stable, with the most recent year at 25%, showcasing consistent value creation for shareholders. While the absolute Cash Conversion Cycle (CCC) remains long, the trend shows significant improvement, decreasing from 315 days in FY22 to 233 days in FY24. This reflects better working capital management, even though high inventory levels persist.
| Metric | 2015-2017 (Avg) | 2018-2020 (Avg) | 2021-2023 (Avg) | FY2024 |
|---|---|---|---|---|
| ROCE (%) | 51.7% | 28.3% | 28.0% | 32.0% |
Financial Health & Prudence
The company's financial health is exceptionally strong, reflecting a prudent and conservative management approach. The balance sheet is a key strength, with the company being virtually debt-free. The Debt-to-Equity ratio for March 2024 is a negligible 0.01, indicating an extremely low reliance on external borrowings and minimal financial risk. This robust financial structure provides significant operational flexibility and a strong buffer against economic downturns. Consequently, the Interest Coverage Ratio is outstanding at over 167 times, meaning operating profits can cover interest expenses many times over. The company also has a practice of sharing profits with shareholders, as evidenced by a consistent, albeit variable, dividend payout history, which included a substantial 79% payout in FY2024. This combination of low leverage and strong profit generation underscores management's commitment to maintaining a resilient financial position.
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|
| Debt/Equity Ratio | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 |
Shareholding & Ownership Structure
The ownership structure reflects strong promoter conviction and significant institutional interest. Promoters maintain a high and stable holding of 66.22%, a clear indicator of their long-term commitment and confidence in the company's prospects. This aligns management's interests closely with those of minority shareholders. Institutional ownership is robust at over 26%. While there has been a slight reduction in FII holding in the past year, this has been more than compensated for by a steady increase in DII holding, which grew from 15.52% in March 2023 to 17.48% in March 2024. This shift suggests growing confidence from domestic institutions in the company's performance and future outlook. The combination of a committed promoter group and strong, growing domestic institutional backing provides a stable and supportive ownership base.
| Metric (%) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Promoters | 70.34% | 70.48% | 66.11% | 66.22% |
| FIIs | 8.37% | 8.64% | 10.00% | 8.54% |
| DIIs | 11.86% | 12.29% | 15.52% | 17.48% |
The overall risk profile is low. The company's primary defense against risk is its fortress-like balance sheet, which is virtually debt-free, minimizing financial and solvency risks. Cash flow generation is strong, and accounting practices appear conservative with no major red flags. The main identifiable risk lies in working capital management, specifically the high levels of inventory and receivables, leading to a long cash conversion cycle. While this ties up capital and presents potential obsolescence or credit risk, the trend in the cash conversion cycle is improving. Given the company's high profitability and strong financial health, it is well-positioned to manage and absorb the potential impacts of this operational risk.
Financial Leverage Risk
The company faces minimal risk from financial leverage. With a Debt-to-Equity ratio of just 0.01 as of March 2024 and total borrowings of only ₹35 crores against an equity base of ₹3,567 crores, the company operates on a virtually debt-free basis. This conservative capital structure insulates it from interest rate fluctuations and eliminates solvency risk associated with high debt loads. The Interest Coverage Ratio of over 167 times further highlights the negligible burden of its interest obligations. This lack of leverage provides the company with substantial financial flexibility to fund growth and withstand economic shocks, making it a very low-risk aspect of its financial profile.
Accounting Quality
The company exhibits indicators of solid accounting quality. Cash from Operations (CFO) consistently tracks Net Profit, with the CFO to Net Profit ratio standing at a healthy 0.96 for FY2024. In the preceding year, cash flow was even stronger, with CFO exceeding Net Profit by 35%. This strong conversion of reported profit into actual cash indicates that earnings are not primarily driven by aggressive accounting policies. Furthermore, the analysis of exceptional items shows they are infrequent and have a minimal impact on the overall profitability, suggesting a clean and transparent profit and loss statement. The underlying reporting appears conservative and grounded in core operational performance.
Working Capital Risk
A notable area of risk pertains to working capital management. The company operates with a long Cash Conversion Cycle (CCC), which stood at 233 days in FY2024. This is primarily driven by high inventory levels and a lengthy collection period for receivables. Inventory Days were 283, which ties up significant capital and exposes the company to risks of price changes and obsolescence. Similarly, Debtor Days were high at 108, indicating a potential credit risk and delays in converting sales to cash. Although the overall CCC has shown improvement from a peak of 315 days in FY22, the absolute levels of inventory and receivables remain elevated, representing a persistent operational risk and an inefficient use of capital.
| Metric (Days) | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Inventory Days | 434 | 347 | 283 | 283 |
| Debtor Days | 93 | 111 | 103 | 108 |
| Cash Conversion Cycle | 315 | 315 | 240 | 233 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 103070.31Bullish
- SMA 203073.91Bearish
- SMA 503083.54Bearish
- EMA 103068.38Bullish
- EMA 203070.76Bullish
- EMA 503066.65Bullish
- DEMA 103065.11Bullish
- DEMA 203068.14Bullish
- DEMA 503080.37Bearish
- TEMA 103063.79Bullish
- TEMA 203064.48Bullish
- TEMA 503080.12Bearish
- MACD-2.16Bearish
- ADX11.72Weak Trend
- IndicatorValueSignal
- RSI50.04Neutral
- CCI-38.88Neutral
- ROC 9-0.46Bearish
- ROC 140.37Bullish
- ROC 250.84Bullish
- Stoch K28.86Neutral
- Stoch D22.82Neutral
- IndicatorValueSignal
- BB Upper3094.40Neutral
- BB Middle3073.91Neutral
- BB Lower3053.43Neutral
- ATR24.02Low Volatility
- IndicatorValueSignal
- MFI58.51Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 103071.93Bearish
- SMA 203067.47Bullish
- SMA 503044.99Bullish
- EMA 103071.47Bearish
- EMA 203071.27Bullish
- EMA 503058.22Bullish
- DEMA 103069.25Bullish
- DEMA 203077.34Bearish
- DEMA 503074.54Bearish
- TEMA 103068.14Bullish
- TEMA 203068.57Bullish
- TEMA 503081.36Bearish
- MACD3.19Bearish
- ADX22.15Weak Trend
- IndicatorValueSignal
- RSI50.91Neutral
- CCI-1.51Neutral
- ROC 9-0.29Bearish
- ROC 141.24Bullish
- ROC 25-2.25Bearish
- Stoch K45.20Neutral
- Stoch D46.91Neutral
- IndicatorValueSignal
- BB Upper3096.70Neutral
- BB Middle3067.46Neutral
- BB Lower3038.23Neutral
- ATR34.30Low Volatility
- IndicatorValueSignal
- MFI56.14Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 103065.66Bullish
- SMA 203068.41Bullish
- SMA 503068.13Bullish
- EMA 103071.74Bearish
- EMA 203062.61Bullish
- EMA 503043.71Bullish
- DEMA 103077.55Bearish
- DEMA 203078.13Bearish
- DEMA 503085.43Bearish
- TEMA 103070.33Bullish
- TEMA 203086.09Bearish
- TEMA 50N/AN/A
- MACD11.79Bearish
- ADX25.58Strong Trend
- IndicatorValueSignal
- RSI52.13Neutral
- CCI-3.64Neutral
- ROC 90.70Bullish
- ROC 14-0.19Bearish
- ROC 256.21Bullish
- Stoch K35.02Neutral
- Stoch D41.48Neutral
- IndicatorValueSignal
- BB Upper3161.93Neutral
- BB Middle3068.41Neutral
- BB Lower2974.90Neutral
- ATR57.15Low Volatility
- IndicatorValueSignal
- MFI52.24Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 103059.89Bullish
- SMA 203035.20Bullish
- SMA 502970.85Bullish
- SMA 1002930.50Bullish
- SMA 2002750.46Bullish
- EMA 103062.76Bullish
- EMA 203047.29Bullish
- EMA 502998.46Bullish
- EMA 1002924.95Bullish
- EMA 2002829.34Bullish
- DEMA 103081.56Bearish
- DEMA 203075.63Bearish
- DEMA 503076.71Bearish
- DEMA 1003054.32Bullish
- DEMA 2002969.43Bullish
- TEMA 103092.09Bearish
- TEMA 203070.36Bullish
- TEMA 503081.98Bearish
- TEMA 1003092.92Bearish
- TEMA 2003024.92Bullish
- MACD21.16Bullish
- ADX15.31Weak Trend
- IndicatorValueSignal
- RSI53.99Neutral
- CCI35.00Neutral
- ROC 144.94Bullish
- ROC 25-1.59Bearish
- Stoch K69.14Neutral
- Stoch D69.62Neutral
- IndicatorValueSignal
- BB Upper3188.17Neutral
- BB Middle3035.20Neutral
- BB Lower2882.23Neutral
- ATR93.96Low Volatility
- IndicatorValueSignal
- MFI64.04Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 202928.99Bullish
- SMA 502734.43Bullish
- EMA 202916.59Bullish
- EMA 502794.67Bullish
- DEMA 203033.49Bullish
- DEMA 502937.23Bullish
- TEMA 203065.46Bullish
- TEMA 502961.31Bullish
- MACD88.48Bullish
- ADX32.26Strong Trend
- IndicatorValueSignal
- RSI59.72Neutral
- CCI139.48Overbought
- ROC 144.65Bullish
- ROC 2518.93Bullish
- Stoch K51.03Neutral
- Stoch D54.16Neutral
- IndicatorValueSignal
- BB Upper3171.43Neutral
- BB Middle2928.99Neutral
- BB Lower2686.55Neutral
- ATR190.80High Volatility
- IndicatorValueSignal
- MFI60.53Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 62850.23Bullish
- SMA 122694.74Bullish
- SMA 242741.84Bullish
- EMA 62824.50Bullish
- EMA 122751.26Bullish
- EMA 242606.71Bullish
- DEMA 62905.55Bullish
- DEMA 122864.71Bullish
- DEMA 242923.26Bullish
- TEMA 62927.53Bullish
- TEMA 122864.50Bullish
- TEMA 242878.09Bullish
- MACD398.75Bearish
- ADX38.65Strong Trend
- IndicatorValueSignal
- RSI61.67Neutral
- CCI98.14Neutral
- ROC 2532.20Bullish
- ROC 50142.63Bullish
- Stoch K46.73Neutral
- Stoch D59.58Neutral
- IndicatorValueSignal
- BB Upper3112.91Neutral
- BB Middle2718.83Neutral
- BB Lower2324.76Neutral
- ATR345.79High Volatility
- IndicatorValueSignal
- MFI59.88Neutral